Tag: Bradley Smith

FORT WORTH, Texas - Despite the challenges of 2020 and the havoc the COVID-19 pandemic has brought to bear on the economy, Brad Smith is bullish on the M&A market for HME. Vertess closed on four deals in the second and third quarters, and is teed up for an even busier Q4 and beyond. “The strategic buyers are extremely active,” said Smith, managing director/partner at the firm. “There are also buyers outside the industry that aren't strategic coming in, buying into health care and...

When AdaptHealth's plan to become a public company was announced in July, ears perked up throughout the HME industry. New IPO listings by DME providers are rare. That could change following Adapt's IPO. To recap, Adapt will combine with DFB Healthcare Acquisitions Corp., which is currently traded on the NASDAQ under symbols DFBH and DFBHW. Once the combination of companies is completed, it is expected that DFB will change its name to AdaptHealth Holding Corp. and remain listed on the NASDAQ under...

HME News asked Bradley Smith, a managing director and partner at Vertess, to explain:“Instead of buying a whole company, like a strategic investor would, a recapitalization typically involves a legacy owner holding on to a minority percent of the stock in the company, referred to as 'rolling equity.'This has two benefits. First, most owners have the majority of their net worth wrapped up in that one company and they don't want to sell the whole thing and walk away. A recapitalization gives...